You are here

Structural Heart

 

After one month, patients with severe aortic stenosis and intermediate surgical risk had improved health status if they underwent transcatheter aortic valve replacement (TAVR) rather than surgical aortic valve replacement (SAVR), according to an analysis of a randomized study. The analysis also found that patients in both groups had similar quality of life outcomes at two years.

David J. Cohen, MD, MSc, and the chief medical officers of three stent companies discuss stents, strategy and the future of healthcare.

SCAI examines the implications of the FDA’s decision to expand the TAVR indication to include patients at intermediate risk for SAVR.

A new transcatheter aortic valve implantation (TAVI) by Boston Scientific has received market approval in Europe.

Eating more spinach and oranges while pregnant could help women prevent heart conditions from developing in their children, new research says.

 

Recent Headlines

Medtronic launches Evolut R 34 mm TAVR system in Europe

Medtronic announced that it had received a CE mark for its Evolut R 34 mm transcatheter aortic valve replacement (TAVR) system. The company also said in the Jan. 17 news release that it had launched the valve in Europe.

CMS approves Watchman study for patients with nonvalvular atrial fibrillation

CMS recently approved a randomized study to assess the Watchman device (Boston Scientific) in patients unsuitable for oral anticoagulation.

AHA statement focuses on managing pregnant women with congenital heart disease

A new scientific statement from the American Heart Association (AHA) provides physicians with guidance on how to treat women with congenital heart disease who become pregnant and manage their risks of miscarriage and other complications.

College football linemen at increased risk of hypertension

Changes in blood pressure and thickening of the heart walls are seen more often in this specific position. 

Swollen joints, anti-inflammatories are hard on the heart

The anti-inflammatory drugs used by osteoarthritis and rheumatoid arthritis patients could be increasing risks of cardiovascular disease (CVD).

Well-fed mothers produce babies with healthy hearts

Prenatal care is vital to the future health of a baby. It’s important for expecting mothers to stop smoking and drinking alcohol and to increase their folic acid intake. But in addition to these steps, mothers must also maintain a healthy weight.

TCT 2016: Sapien valve is durable up to 5 years in patients with severe aortic stenosis

Patients with severe aortic stenosis who underwent transcatheter aortic valve replacement (TAVR) with the Sapien first generation device had positive hemodynamics up to five years following implant, according to an analysis of a randomized trial.

TCT 2016: Quality of life at two years is similar for TAVR, SAVR patients

After one month, patients with severe aortic stenosis and intermediate surgical risk had improved health status if they underwent transcatheter aortic valve replacement (TAVR) rather than surgical aortic valve replacement (SAVR), according to an analysis of a randomized study. The analysis also found that patients in both groups had similar quality of life outcomes at two years.

If You Give a Cardiologist a Crystal Ball

For this issue, we gave cardiologists a crystal ball, figuratively, of course, and asked them what they saw for their specialty’s future.

FDA expands approval for Medtronic’s CoreValve Evolut R system in larger size

The FDA approved Medtronic’s CoreValve Evolut R system in a new 34 mm size valve for patients undergoing transcatheter aortic valve replacement (TAVR).

Pages